Missak Haigentz, MD, Joins Atlantic Health System Cancer Care
Missak Haigentz, MD
Head and neck and lung cancer researcher Missak Haigentz, MD, has joined Atlantic Health System Cancer Care as Chief of Hematology and Oncology at Morristown Medical Center and Medical Director of Atlantic Hematology and Oncology for Atlantic Medical Group at the Carol G. Simon Cancer Center. Dr. Haigentz is a cancer physician who has extensive expertise in the design and implementation of innovative clinical trials to improve the lives of patients.
Dr. Haigentz joins Atlantic Health System from the National Cancer Institute–designated Albert Einstein Cancer Center in New York, where he served as Director of the Clinical Trials Office and led several national and multicenter trials of cancer drugs. He was also Professor of Medicine (Oncology) and Otorhinolaryngology–Head and Neck Surgery at the Albert Einstein College of Medicine.
A physician, clinical researcher, and educator, Dr. Haigentz is recognized as an expert in cancers of the head and neck (including thyroid cancers) and lung cancers. His research has received funding from the National Institutes of Health and the Conquer Cancer Foundation of ASCO. He has served on the editorial board of the Journal of Clinical Oncology and has held several leadership roles, such as President of the New York Head and Neck Society (2014–2015).
Dr. Haigentz earned his medical degree from the New Jersey Medical School. After completing residency training in internal medicine at the New Jersey Medical School (where he also served as Chief Resident), he received subspecialty fellowship training in hematology and oncology at the New York University School of Medicine. ■